Benzodiazepine Market: Key Growth Factors and Opportunity Analysis by 2027
Market Highlights
Benzodiazepines (BZD) are a class of psychoactive drugs with sedative,
hypnotic (sleep-inducing), anti-anxiety, anticonvulsant, and muscle relaxant
properties. Benzodiazepines (BZD) are useful in treating anxiety, insomnia, agitation,
seizures, muscle spasms and alcohol withdrawal.
The sale of Benzodiazepine has been declining due to their addictive
side effects and the rise of alternate drugs such as selective serotonin
reuptake inhibitors. However the last few years have witnessed a moderate rise
in the sale of Benzodiazepines. The lack of
efficacy and slow onset of action of selective serotonin reuptake inhibitors
along with the fear of falling back on first generation anti-psychotic
(barbiturate class) drugs have negated any market moves against
Benzodiazepines. Development of short acting Benzodiazepines is an additional
advantage in favour of barbiturates.
Some more restraints hampering the market growth are highly competitive
and segmented market and a shift towards non-pharmacological therapies.
Global Benzodiazepine market:
The Global Benzodiazepine
Market has been evaluated as a slowly growing market and it is expected
that the market will reflect sluggish growth figures in future. The global Benzodiazepine
market is expected to grow with CAGR of ~ 1.5% to 2.3 % during the forecast
period.
The major participants of this market are: AstraZeneca plc, Eli
Lilly and Company, GlaxoSmithKline plc, Pfizer, Inc., Sanofi S.A. and
Merck & Co., Inc.
Regional Analysis:
Depending on geographic region, Benzodiazepine market is segmented into
four key regions: Americas, Europe, Asia Pacific, and Middle East & Africa.
Globally developed countries led by North America is the largest market for
Benzodiazepines. Europe is the second-largest market for Benzodiazepines. Asia
pacific region is expected to be fastest growing region in Benzodiazepine
market due to increasing spending on healthcare infrastructure.
Segmentation:
Global Benzodiazepines market has been segmented on the basis of
application which comprises of disposable, reusable and others.
On the basis of application; market is segmented into anxiety,
insomnia, agitation, seizures, muscle spasms and alcohol withdrawal and as
anaesthesia supplements.
On the basis of time of action; market is segmented into long acting
and short acting Benzodiazepines.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the
complexity of various industries through our Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed
Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market
research and intelligence services to our clients. Our market research studies
by products, services, technologies, applications, end users, and market
players for global, regional, and country level market segments, enable our
clients to see more, know more, and do more, which help to answer all their
most important questions.
In order to stay updated with technology and work process of the
industry, MRFR often plans & conducts meet with the industry experts and
industrial visits for its research analyst members.
Contact:
Akash Anand,
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: akash.anand@marketresearchfuture.com
Comments
Post a Comment